Opus Genetics Statistics Share Statistics Opus Genetics has 59.66M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 59.66M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares 14,990 FTD / Avg. Volume 1.42%
Short Selling Information The latest short interest is 495.95K, so 0.83% of the outstanding
shares have been sold short.
Short Interest 495.95K Short % of Shares Out 0.83% Short % of Float 0.87% Short Ratio (days to cover) 1.85
Valuation Ratios The PE ratio is -0.55 and the forward
PE ratio is -1.6.
Opus Genetics's PEG ratio is
0.
PE Ratio -0.55 Forward PE -1.6 PS Ratio 2.89 Forward PS 2.9 PB Ratio 4.73 P/FCF Ratio -1.24 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Opus Genetics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.24,
with a Debt / Equity ratio of 0.
Current Ratio 3.24 Quick Ratio 3.24 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $610.67K Profits Per Employee $-3.2M Employee Count 18 Asset Turnover 0.3 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.29, so Opus Genetics's
price volatility has been higher than the market average.
Beta 0.29 52-Week Price Change n/a 50-Day Moving Average 1.05 200-Day Moving Average 1.06 Relative Strength Index (RSI) 46.11 Average Volume (20 Days) 1,057,319
Income Statement In the last 12 months, Opus Genetics had revenue of 10.99M
and earned -57.53M
in profits. Earnings per share was -2.15.
Revenue 10.99M Gross Profit 10.98M Operating Income -62.07M Net Income -57.53M EBITDA -57.52M EBIT -57.53M Earnings Per Share (EPS) -2.15
Full Income Statement Balance Sheet The company has 30.32M in cash and 0 in
debt, giving a net cash position of 30.32M.
Cash & Cash Equivalents 30.32M Total Debt n/a Net Cash n/a Retained Earnings -139M Total Assets 48.17M Working Capital 23.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -25.58M
and capital expenditures 0, giving a free cash flow of -25.58M.
Operating Cash Flow -25.58M Capital Expenditures n/a Free Cash Flow -25.58M FCF Per Share -0.96
Full Cash Flow Statement Margins Gross margin is 99.91%, with operating and profit margins of -564.72% and -523.4%.
Gross Margin 99.91% Operating Margin -564.72% Pretax Margin -523.4% Profit Margin -523.4% EBITDA Margin -523.31% EBIT Margin -564.72% FCF Margin -232.68%
Dividends & Yields IRD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IRD is $6,
which is 460.7% higher than the current price. The consensus rating is "Buy".
Price Target $6 Price Target Difference 460.7% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 6, 2020. It was a
backward
split with a ratio of 1:4.
Last Split Date Nov 6, 2020 Split Type backward Split Ratio 1:4
Scores Altman Z-Score -6.47 Piotroski F-Score 1
